Podcast: Repurposing Disappointments Impact on Parkinson’s Drug Development

Podcast: Repurposing Disappointments Impact on Parkinson’s Drug Development
Last week, findings from the STEADY-PD trial of blood pressure drug isradipine for Parkinson's were released that showed no significant benefit on symptoms. In December, the SURE-PD trial of inosine, a precursor to the antioxidant urate, ended early after it too showed no benefit in people with Parkinson's disease. In our latest podcast, Contributing Editor Dave Iverson speaks with leaders ... read more
Source: Published on 2019-05-08